401-93-4 Usage
General Description
3-Chloro-5-nitrobenzotrifluoride is a specialized chemical compound characterized by the presence of chlorine, nitro group and trifluoromethyl group attached to a benzene ring. It is represented by the molecular formula C7H3ClF3NO2. 3-Chloro-5-nitrobenzotrifluoride has distinctive properties due to its constituent elements and the structure, making it useful in various scientific and industrial processes. It is often used as a reagent or a building block in the synthesis of more complex chemical compounds. The precise handling and usage of this chemical need to be executed due to its potentially harmful effects.
Check Digit Verification of cas no
The CAS Registry Mumber 401-93-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,0 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 401-93:
(5*4)+(4*0)+(3*1)+(2*9)+(1*3)=44
44 % 10 = 4
So 401-93-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H5F3N2O2/c8-7(9,10)4-1-5(11)3-6(2-4)12(13)14/h1-3H,11H2
401-93-4Relevant articles and documents
Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
-
, (2008/06/13)
The invention relates to pyridine derivatives of formula (I), wherein the substituents and symbols are defined as indicated in the description, processes for the preparation thereof, their usage in the preparation of a pharmaceutical composition for the treatment of a disease which responds to an inhibition of angiogenesis, and pharmaceutical compositions containing such compounds.
Pyridazinedione compounds useful in treating neurological disorders
-
, (2008/06/13)
The present invention relates to pyridazino[4,5-b]quinolines, and pharmaceutically useful salts thereof, which are excitatory amino acid antagonists and which are useful when such antagonism is desired such as in the treatment of neurological disorders. The invention further provides pharmaceutical compositions containing pyridazino[4,5-b]quinolines as active ingredient, and methods for the treatment of neurological disorders.